Rate of CRL4CRBN substrate Ikaros and Aiolos degradation...

Blood Cancer Journal 2015 / 10 Vol. 5; Iss. 10

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4

Bjorklund, C C, Lu, L, Kang, J, Hagner, P R, Havens, C G, Amatangelo, M, Wang, M, Ren, Y, Couto, S, Breider, M, Ning, Y, Gandhi, A K, Daniel, T O, Chopra, R, Klippel, A, Thakurta, A G
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2015.66
Date:
October, 2015
File:
PDF, 3.68 MB
english, 2015
Conversion to is in progress
Conversion to is failed